Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abuse, accessed, accrediated, adjuvant, AMA, andPTEN, Appeal, appealing, ASC, ASU, Australia, benign, biochemical, BRAC, carryover, Circuit, closing, cognizant, confidence, Conversely, correlation, CPT, creating, CRSP, cycle, database, detectingMYH, detectingPTEN, disaggregation, dividing, division, Dreismann, Editorial, eventually, extend, flourouracil, forecast, forthcoming, fraud, Genitourinary, gland, graph, half, Heiner, HGSI, higher, highlighted, HITECH, HITECT, immuno, input, irrevocable, isolatedBRCA, isolatedMYH, isolatedPTEN, Japan, Judge, lawrence, left, louise, Lynch, main, makeup, man, media, median, men, met, midwestern, miniumum, missing, modest, monetary, MPCW, nanoparticle, notification, notify, nucleic, omission, onDPYD, open, pancreatic, Panel, Pathology, phanstiel, PHI, presence, prominent, promptly, propriety, prostatectomy, provisional, quantitative, quantitatively, radical, reinvest, Reinvestment, representation, repurchase, settlement, solicit, sought, statutory, subleasee, Subtitle, Subtopic, suppressor, surgical, Sweet, Symposium, terminology, tissue, Topic, toPTEN, undertaken, unwarranted, usingMYH, Workgroup, Zealand
Removed:
accounted, accreted, accretion, Adrian, analytical, Attestation, attiyeh, blood, Bulletin, category, chemical, consultation, counsel, Cytovia, distribute, DNA, EITF, epicept, exceeded, factor, FIN, foreseeable, genotype, Hobden, interpretation, labeling, library, lifestyle, liquid, liquidation, Maxim, measuring, medication, Multivariate, proportionate, realizability, recent, reviewed, ultimate, unallocated, underwritten, validity, varying, VIII
Filing tables
Filing exhibits
- 10-K Annual report
- 10.12.2 Amendment No. 1 Dated November 11, 2009 to Sublease Agreement
- 10.12.3 Amendment No. 2 Dated February 19, 2010 to Sublease Agreement
- 21.1 List of Subdidiaries of Myriad Genetics, Inc.
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of the CEO Pursuant to Section 302
- 31.2 Certification of the CFO Pursuant to Section 302
- 32 Certification of the CEO & CFO Pursuant to Section 906
Related press release
MYGN similar filings
Filing view
External links
Exhibit 21.1
LIST OF SUBSIDIARIES OF MYRIAD GENETICS, INC.
Company Name | Jurisdiction of Incorporation | |
Myriad Genetic Laboratories, Inc. | Delaware | |
Myriad Financial, Inc. | Utah | |
Myriad Therapeutics, Inc. | Delaware |
Each of the subsidiaries is wholly-owned by Myriad Genetics, Inc., a Delaware corporation.